Collaboration Inquiries
Latest News Press Release Recent Articles Current & Upcoming Meetings and Events Past Meetings and Events
Contact Information
VacciMax® Platform Advantage VacciMax® Proof of Concept VacciMax® Platform Scale-up
Board of Directors Corporate Profile In Memorium Scientific Advisors Senior Management Technical Advisors
Contact Us Partners Press Releases Spayvac Vaccimax Corporate Profile Home
  HOME | PROFILE | VACCIMAX® PLATFORM | PRESS | PARTNERS | CAREERS | CONTACT  


Delivering Breakthrough Vaccines

IVT’s goal is to generate sustainable, long-term revenues by developing and commercializing VacciMax® based vaccines through early clinical development, multiple partnerships and licensing agreements with major vaccine companies.

LATEST NEWS

Vaccine Development Aided by New Techniques

On The Move - ImmunoVaccine Technologis Inc. has been selected as one of Canada's Top 10 Life Sciences Companies

Vaccine breakthrough heralds new cancer treatment

ImmunoVaccine Technologies’ DepoVax™ Shows Positive Results for Cancer and Infectious Diseases

ImmunoVaccine Technologies selected as Canada's Top 10™ Life Sciences Companies

 

PAST MEETINGS AND EVENTS

Events


Bio-Europe 2008

 

November 17 - 19, 2008

m:con Congress Center Rosengarten
Manheim/Heidelberg, Germany

 

Jeff Skinner, Director Business Development will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail js.ivt@immunovaccine.com.


Related Link: http://www.ebdgroup.com/bioeurope


iSBTc 23rd Annual Meeting

 

October 31 - November 2, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA

 

Dr. Marc Mansour, Vice President R&D, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail mm.ivt@immunovaccine.com.


Related Link: http://www.isbtc.org/meetings/am08/


The 7th Annual BIO Investor Forum

 

October 29-31, 2008
Palace Hotel
San Francisco, CA

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director Corporate Strategy will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://investorforum.bio.org/opencms/bif/2008/index.jsp


16th Annual BioPartnering Europe


October 12-14, 2008

QEII Conference Centre
Broad Sanctuary, Westminster
London, United Kingdom SW1P 3EE

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director Corporate Strategy, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.techvision.com/bpe/


BioPort 2008

 

October 8 -9,2008

Cunard Centre

Halifax, Nova Scotia

 

Dr. Randal Chase, President & CEO, Brian Lowe, Vice President and Jeff Skinner, Director Business Development, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://bionova.ns.ca/index.cfm?fuseaction=text.&str_cmpID=7347


BioContact Quebec

 

Château Frontenac, Québec
October 1-3, 2008

 

Dr. Randal Chase, President & CEO, Ella Korets-Smith, Director Corporate Strategy and Jeff Skinner, Director Business Development will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.biocontact.qc.ca/


BARDA Industry Day

 

The HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2008 and BARDA Industry Day

September 24 - 26, 2008


Crystal Gateway Marriott

1700 Jefferson Davis Highway
Arlington, VA 22202

 

Dr. Marc Mansour, Vice President R&D, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail mm.ivt@immunovaccine.com.


Related Link: http://www.blsmeetings.net/phemc/workshopoverview.cfm


InnoVet

 

International Veterinary Business Conference

 

4th Edition, 2008
September 22 to 24, 2008

Hotel Des Seigneurs

1200 rue Johnson Ouest

Quebec

 

Ms. Ella Korets-Smith, Director Business Development, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.

 


Related Link: http://www.innovet.ca/index.php


BioPharm America 2008

 

September 9-10, 2008
Grand Hyatt Hotel
Atlanta, GA, USA

 

Ms. Ella Korets-Smith, Director Business Development, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.ebdgroup.com/bpa/


BIO Internation Convention 2008

The Global Event for Biotechnology

San Diego, CA

June 17 - 20, 2008

 

 

Dr. Randal Chase, President & CEO, Dr. Marc Mansour, Vice President, R&D and Ella Korets-Smith, Director of Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




44th ASCO Annual Meeting

May 30-June 3, 2008
McCormick Place
Chicago, Illinois

 

Dr. Marc Mansour, Vice President R&D, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail mm.ivt@immunovaccine.com.




C21 BioVentures

May 20 - 22, 2008

Napa, California

The Meritage Resort

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




BIO Finance

Toronto Eaton Centre

Toronto, Ontario, Canada

May 6 - 8, 2008

 

 

 

Dr. Marc Mansour, Vice President R&D, and Ella Korets-Smith, Director Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




World Vaccine Congress Washington 2008

April 21 - 24, 2008

Hyatt Regency Crystal City Arlington, VA

 

Dr. Randal Chase, President & CEO, and Ella Korets-Smith, Director Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




BIO-Europe Spring 2008

Palacio Municipal de Congresos

Madrid, Spain

April 7 - 9, 2008

 

 

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director of Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




BIO Windhover

Grand Hyatt, New York City

March 16 - 18, 2008

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director of Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




Sachs Associates - 7th Annual North America Forum for Investing and Partnering in Biotech Fairmont Copley Plaza, Boston

February 25 - 26, 2008

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Director of Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.




BIO CEO & Investor Conference

February 11 - 13, 2008 in New York City

Waldorf-Astoria

 

Dr. Randal Chase, President & CEO will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://ceo.bio.org/opencms/ceo/2008/index.jsp


6th Annual BioPartnering North America

North America's Most Innovative Partnering Conference

Westin Bayshore Resort, Vancouver, BC

February 3 - 5, 2008

 

Dr. Randal Chase, President & CEO and Ella Korets-Smith, Associate Director of Business Development, will be attending this conference.  To arrange contact, please call 902-492-1819 or e-mail eks.ivt@immunovaccine.com.

 

 


Related Link: http://www.techvision.com/bpn/


ILS 2007 Annual Meeting

Liposome Advances: Recent Progress in Drug and Vaccine Delivery

School of Pharmacy, University of London

London, UK

December 8 - 11, 2007

 

Dr. Marc Mansour, Vice President R&D, will be attending this meeting.  To arrange contact please call 902-492-1819 or mm.ivt@immunovaccine.com

 


Related Link: http://www.liposome.org/frame_ils2006.html


3rd Meeting on Influenza Vaccines that Induce Broad Spectrum and Long Lasting Immune Responses

WHO Headquarters, Geneva

December 3 - 4, 2007

 

Dr. Randal Chase, President & CEO, and Dr. Marc Mansour, Vice President R&D, have been invited to attend this meeting.  To arrange contact please call 902-492-1819 or mm.ivt@immunovaccine.com


Related Link: http://www.who.int/en/


iSBTc Primer on Tumor Immunology and Biological Therapy

November 1 - 4, 2007

Seaport World Trade Center

Boston, MA

 

Genevieve Weir, Research Associate, will be attending this meeting on November 1st, 2007.  To arrange a meeting, please contact 902-421-5734 or e-mail gw.ivt@immunovaccine.com

 

 

 

 


Related Link: http://www.isbtc.org/


InnoVet 2007 Prince Edward Island

October 14 - 16, 2007

International Veterinary Business Conference

Charlottetown, Prince Edward Island

 

Ms. Ella Korets-Smith, Associate Director of Business Development, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.innovet.ca


World Vaccine Congress 2007

October 8 - 10, 2007

Palais des Congrès de Lyon

Lyon, France

 

Ms. Ella Korets-Smith, Associate Director of Business Development, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.terrapinn.com/2007/wvcl/


BioContact Québec 2007

October 3 - 5, 2007

Château Frontenac, Quebec

 

Dr. Randal Chase, President & CEO, and Ms. Ella Korets-Smith, Associate Director of Business Development, will be attending this meeting.  To arrange a meeting, please contact Ms. Korets-Smith at 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.biocontact.qc.ca/


9th Annual Colloquium on Cancer Vaccines and Immunotherapy

September 27 - 29, 2007

Hyatt Regency Bethesda, Bethesda, MD

 

Ms. Ella Korets-Smith, Associate Director of Business Development, will be attending this meeting on September 28th & 29th, 2007.  To arrange a meeting, please contact 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.sabin.org/programs/cvc/cvc_meetings_2007.html


BIOPORT ATLANTIC 2007

September 26 - 27, 2008

Halifax, Nova Scotia

World Trade and Convention Centre

 

Mr. Brian Lowe, Chief Operating Officer, and Ms. Ella Korets-Smith, Associate Director of Business Development, will be attending this event.  To arrange contact, please call Ms. Korets-Smith at 902-492-1819 or 902-401-7634 or e-mail eks.ivt@immunovaccine.com.


Related Link: http://www.bionova.ca/index.cfm?reqID=06282007120153&fuseaction=text.&str_cmpID=7347


ImVacS 2nd Annual Targeted Immunotherapeutics & Vaccine Summit

August 21 - 24, 2007

Cambridge, MA

 

Marriott Chateau Champlain Hotel

 

Dr. Mohan Karkada, Director of Biological Research, will be attending this meeting.  To arrange a meeting, please contact 902-492-1819 or e-mail mk.ivt@immunovaccine.com.

 

 

 

 


Related Link: http://www.healthtech.com/2007/imt/


BIO VentureForum East 2007

June 18 - 20, 2007

Montreal, Quebec

 

Marriot Chateau Champlain Hotel

 

To arrange a meeting, please contact 902-492-1819.


Related Link: http://bvf-east.bio.org/opencms/bvfeast/2007/index.jsp


2007 ASCO Annual Meeting

 

43rd ASCO Annual Meeting

June 1- 5, 2007

McCormick Place

Chicago, IL

 

Dr. Marc Mansour, Chief Science Officer, will be attending this meeting.  To arrange contact, please call 902-492-1819 or e-mail mm.ivt@immunovaccine.com


Related Link: http://www.asco.org


BIO International Convention

The Global Event for Biotechnology

May 6 - 9, 2007

Boston Convention & Exhibition Centre

Boston, MA

 

For more information, please contact Ella Korets-Smith.  Call:  902-492-1819 or eks.ivt@immunovaccine.com

 


Related Link: http://www.bio2007.org


BIO Finance 2007

FUNDING LIFESCIENCES COMPANIES

April 24 - 26, 2007

Toronto Marriot Eaton Centre

525 Bay Street

Toronto, ON  M5G 2L2

 

A team from IVT will be attending this event.  For more information please contact Dr. Marc Mansour, Chief Science Officer.  Call: 902-492-1819 or mm.ivt@immunovaccine.com

 


Related Link: http://www.biofinance.ca


FDA/NCI Workshop

Bringing Therapeutic Cancer Vaccines and Immunotherapies Through Development to Licensure

February 8 - 9, 2007

Natacher Conference Centre, NIH

45 Center Drive

Bethesda, MD  20892

 

Dr. Marc Mansour, Chief Science Officer and Dr. Pirouz Daftarian, Head Scientist, Cancer Research will be attending this workshop.  To arrange contact, please call 902-492-1819 or e-mail mm.ivt@immunovaccine.com

 

 

 


Related Link: http://www.fda.gov/cber/meetings/cancer020807.htm

ILS 2006 Annual Meeting

December 9 - 12, 2006

School of Pharmacy, University of London, London, UK

 

Liposomes Advances: Progress in Drug and Vaccine Delivery

 

The International Liposome Society 2006 Annual Meeting will deal critically with major areas of liposomology including aspects of human physiology related to liposomal behaviour in vivo, application of liposomes in antimicrobial and cancer treatment, gene therapy, conventional and genetic vaccines, topical therapy as well as technical advances and intellectual property issues.

 

For more information, please contact Dr. Marc Mansour, Chief Science Officer.  Call: 902-492-1819 or e-mail mm.ivt@immunovaccine.com

 


Related Link: http://www.liposome.org/pages/ils2006.html


6th Meeting of the Cancer Vaccine Consortium

November  10 - 11, 2006

Omni Shoreham Hotel, Washington, DC

 

TOWARD KNOWLEDGE SHARING:

IMMUNOTHERAPIES FOR CANCER AND INFECTIOUS DISEASE

 

For more information, please contact Dr. Pirouz Daftarian, Head Scientist, Cancer Research.  Call: (902) 492-0465 or (902) 401-7934

E-mail: pd.ivt@immunovaccine.com

 


Related Link: http://www.sabin.org/CVC_Meetings.htm


8th Annual Colloquium on Cancer Vaccines and Immunotherapy

November 9-10, 2006

Omni Shoreham Hotel, Washington, DC

 

ENABLING COMBINATION THERAPY APPROACHES

 

For more information, please contact Dr. Pirouz Daftarian, Head Scientist, Cancer Research.  Call: (902) 492-0465 or (902) 401-7934

E-mail: pd.ivt@immunovaccine.com

 


Related Link: http://www.sabin.org/CVC_Meetings.htm


iSBTc 21st Annual Meeting

October 26 - 29, 2006 

Hyatt Regency Century Plaza

Century City, Los Angeles, California

 

 

Two abstracts describing IVT's preclinical reports on eradication of established melanoma tumors and the efficacy of VacciMax® in older mice were accepted as poster presentation at the 21st Annual Meeting of The International Society for Biological Therapy of Cancer (iSBTc).

 

For more information, please contact Dr. Pirouz Daftarian, Head Scientist, Cancer Research.  Call: (902) 492-0465 or (902) 401-7934

E-mail: pd.ivt@immunovaccine.com

 


Related Link: http://www.isbtc.org/meetings/am06/


The 2nd International Conference on Modern Vaccines Adjuvants & Delivery Systems (MVADS 2006)

September 12 - 14, 2006

The Royal Society of Medicine, London, UK

 

For more information, please contact Dr. Marc Mansour, Chief Science Officer, by email:  mm.ivt@immunovaccine.com or on the Message Board on the MVADS 2006 site.


Related Link: http://www.meetingsmanagement.com/mvads_2006/


Oral Presentation at 23rd International Papillomavirus Conference

September 1-7, 2006

Hilton Hotel Prague, Prague, Czech Republic

 

An abstract describing further development of IVT's cancer vaccine technology in HLA-A2 transgenic mice has been accepted for presentation at the 23rd International Papillomavirus Conference, Prague, 2006.

 

For more information, please contact Dr. Pirouz Daftarian, Head Scientist, Cancer Research.  Call: (902) 492-0465 or (902) 401-7934.

E-mail: pd.ivt@immunovaccine.com

 

 


Related Link: http://www.ipvconference2006.org/default.aspx?menu=134&submenu=128


Ninth Annual Conference on Vaccine Research

May 8 to 10, 2006

Baltimore Marriot Inner Harbor Hotel, Balitmore, MD

 

For more information, please contact Dr. Marc Mansour, Chief Science Officer

 

Phone:  (902) 421-5733

Email:  mm.ivt@immunovaccine.com


Related Link: http://www.nfid.org/conferences/vaccine06/


Bio 2006 - Chicago - April 2006

 

 

 


Related Link: http://www.bio.org


AACR Annual Meeting 2006

April 1 to 5, 2006

Washington Convention Centre, Washington, DC

The AACR Annual Meeting is the world's largest and most comprehensive gathering of professionals in the cancer field, encompassing basic, translational, and clinical research.

 

For more information, please contact Dr. Pirouz Daftarian, Head Scientist, Cancer Research.  Call: (902) 492-0465 or (902) 401-7934 or e-mail pd.ivt@immunovaccine.com

 


Related Link: http://www.aacr.org/page5870.aspx


Advances in the Understanding and Treatment of Melanoma

January 18 - 23, 2006 Hilton Sante Fe - Historic Plaza, Sante Fe, New Mexico
Related Link: http://www.keystonesymposia.org


World Vaccine Conference - Montreal - 2006


Related Link: http://www.lifescienceworld.com

INTERNATIONAL LIPOSOME SOCIETY 2005 ANNUAL MEETING

December 12 - 16, 2005 School of Pharmacy, University of London, London The first International Liposome Society Annual Meeting will focus on recent progress and trends in the use of liposomes and other lipid-based systems in drug and vaccine delivery and targeting. Liposome Advances: Progress in Drug and Vaccine Delivery.
Related Link: http://www.liposome.org/pages/annual.html


iSBTc 20th Annual Meeting

An abstract has been submitted to the 20th annual meeting of International Society for Biological Therapy of Cancer (iSBTc).
Related Link: http://www.isbtc.org/meetings.html

BioContact - Quebec City - October 2005

BioContact Quebec 2005 is a biopharmaceutical partnerhsip symposium gathering over 1200 participants.
Related Link: http://www.biocontact.qc.ca


Vaccine Congress Berlin 2005

New Approaches to Vaccine Development
From the bench to the field
Related Link: http://www.vaccine-berlin2005.org/

CVADD 2005

A New International Conference Cancer Vaccines/Adjuvants/Delivery for the Next Decade

CVADD 2005 – 5-7 September 2005
Pestana Palace Hotel, Lisbon, Portugal

CANCER VACCINES/ADJUVANTS/DELIVERY FOR THE NEXT DECADE – CVADD 2005 is a
new and important international conference that will offer a forum for researchers into
cancer vaccines to meet and discuss the latest developments/initiatives in this
important field of vaccine research.
Related Link: http://www.meetingsmanagement.com/pdf/CVADD_2005.pdf


BIO 2005 - Philadelphia - June 2005


Related Link: http://www.bio.org

  HOME | PROFILE | PRODUCT | PRESS | PARTNERS | CAREERS | CONTACT